Our Fellows
At Vanderbilt, our fellows achieve outstanding clinical and research goals during and after their fellowships. Our fellows go on to lead academic urology and research programs and train future leaders in our field.
Current Fellows
-
Avi Baskin, MD
FellowUrologic Oncology FellowshipResidency: University of California, San Francisco
-
Cameron Britton, MD
FellowUrologic Oncology FellowshipResidency: Mayo Clinic, Rochester, Minnesota
Former Fellows
-
Ruchika Talwar, MD, MMHC
Assistant ProfessorDepartment of UrologyMedical DirectorEpisodes of Care, Population HealthDivision of Urologic OncologyMedical School: Rutgers New Jersey Medical School, Newark, NJ
Residency: University of Pennsylvania, Philadelphia, PA
Fellowship: Vanderbilt University Medical CenterDr. Ruchika Talwar is a urologic oncologist at Vanderbilt University Medical Center and Medical Director in the Episodes of Care Office, where she leads and operationalizes VUMC’s specialty value-based care programs, including Medicare models and the innovative MyHealth Bundles program. She is a residency graduate from the University of Pennsylvania in Philadelphia, PA, where she was affiliated with the Leonard Davis Institute of Health Economics at the Wharton School. She completed a Society of Urologic Oncology (SUO) fellowship and Masters of Management in Healthcare at Vanderbilt University. Dr. Talwar has served in several national leadership roles within organized medicine, including Chair of the American Urological Association's residents and fellows committee, the Health Policy, Young Urologic Oncologists, and Women in Urologic Oncology Committees of the SUO, and is currently the Fundraising Chair for the AUAPAC. She held the H. Logan Holtgrewe Legislative Fellowship in 2022, when she spent time working on Capitol Hill in the office of Congressman Darren Soto (FL-09). Dr. Talwar’s clinical practice includes both robotic and open approaches to urologic cancer surgery, with a focus on patient-centered care. Her academic work in health policy, value transformation, drug pricing, and costs of care has been published in several JAMA journals and the Journal of Clinical Oncology. She makes several trips a year to Washington, DC, meeting with Congressional representatives as a passionate advocate for improving the quality of care provided to patients in the US.
-
Bashir Al Hussein Al Awamlh, MD
Assistant ProfessorWeill Cornell Medicine, New York, NYMedical School: University of Jordan, Amman, Jordan
Residency: New York Presbyterian/Weill Cornell Medicine, New York, NY
Fellowship: Vanderbilt University Medical Center -
Woodson Smelser, MD
Assistant ProfessorWashington University, St. Louis, MOMedical School: University of Missouri
Residency: University of Kansas Medical Center
Fellowship: Vanderbilt University Medical Center -
Christopher Wallis, MD, PhD
Assistant Professor of UrologyDepartment of Surgery, University of Toronto and Urologic Oncologist, Mount Sinai HospitalMedical School: University of British Columbia
Residency: University of Toronto
Fellowship: Vanderbilt University Medical Center, Nashville, TN -
Amy N. Luckenbaugh, MD, FACS
Assistant ProfessorDepartment of UrologyDivision of Urologic OncologyMedical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic CancerDr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as the chair of Women in Urologic Oncology, and the secretary for the Society of Women in Urology, and through her research aims to mitigate variation in healthcare delivery.
-
Aaron Laviana, MD, MBA
Assistant Professor of Surgery and Perioperative CareUniversity of Texas at Austin Dell Medical SchoolMedical School: Georgetown University, School of Medicine
Residency: University of California, Los Angeles
Fellowship: Vanderbilt Urologic Oncology Fellowship
-
Daniel Lee, MD, MS
Assistant ProfessorPerelman Center for Advanced Medicine, Penn UrologyMedical School: SUNY Stony Brook Medical School
Residency: New York Presbyterian Hospital-Weill Cornell Medical Center
Fellowship: Vanderbilt Urologic Oncology Fellowship - 2016-2018 -
Mark Tyson, MD
Assistant Professor of UrologyMayo Clinic PhoenixMedical School: Dartmouth Medical School
Residency: Mayo Clinic, Arizona
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Kristen R. Scarpato, MD, MPH
Associate ProfessorDepartment of UrologyResidency Program DirectorDepartment of UrologyVice Chair of EducationDepartment of UrologyDivision of Urologic OncologyMedical Degree: Tufts University School of Medicine
Residency: University of Connecticut Health Center
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Genitourinary Cancer, Prostate Cancer, Prostatectomy, Ultrasound Fusion Biopsy/Artemis
Dr. Scarpato, MD, MPH, is an Associate Professor and the Director of the Urology Residency Program and Vice Chair of Education. She has interests in resident and medical student education, surgical simulation, and mentorship. She remains committed to advancing the field of urology through education and maintains a strong interest in both patient and resident education. She enjoys collaborating on educational endeavors with numerous local and national organizations. Dr. Scarpato’s clinical practice focuses on the diagnosis and management of bladder and prostate cancer. She has a particular interest in focal therapy and salvage prostate ablation, as well as advanced prostate cancer.
-
Brock B. O’Neil, MD
Assistant ProfessorUniversity of UtahMedical School: University of Rochester
Residency: University of Utah
Fellowship: Vanderbilt Urologic Oncology Fellowship -
John Eifler, MD
First UrologyMedical School: New York Presbyterian Hospital-Weill Cornell Medical Center
Residency: Johns Hopkins
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Medical School: New York Medical College
Residency: University of California, Irvine
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Jeffrey C Bassett, MD, MPH
Hoag HospitalMedical School: University of Pittsburgh School of Medicine
Residency: David Geffen School of Medicine at UCLA
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Medical School: University of Chicago, Pritzker School of Medicine
Residency: Columbia University Medical Center
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Matthew J. Resnick, MD, MPH
Chief Medical OfficerEmbold HealthMedical School: University of Pennsylvania, School of Medicine
Residency: University of Pennsylvania
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Kirk A Keegan III, MD, MPH
Senior Medical DirectorJanssen Research and DevelopmentMedical School: Georgetown University, Washington D.C.
Residency: University of California, Davis
Fellowship: Vanderbilt University Medical Center -
Todd Morgan, MD
Urology Chief, Division of Urologic OncologyUniversity of MichiganMedical School: Harvard Medical School
Residency: University of Washington
Fellowship: Vanderbilt Urologic Oncology Fellowship
-
Alison M. Christie, MD
Section Chief, UrologyJames H. Quillen VA Medical CenterMedical School: Jefferson Medical College
Residency: University of Michigan Health System
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Carl J. Bischoff, MD
Urology AustinMedical School: Louisiana State University Medical School
Residency: University of Florida at Gainesville
Fellowship: Vanderbilt Urologic Oncology Fellowship -
Daniel A. Barocas, MD, MPH, FACS
ProfessorDepartment of UrologyExecutive Vice ChairDepartment of UrologyDivision of Urologic OncologyMedical School: Johns Hopkins University School of Medicine
Residency: New York Presbyterian Hospital-Weill Cornell Medical Center
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Genitourinary Cancer, Prostate Cancer, Kidney Cancer, Bladder Cancer, Laparoscopy and RoboticsDr. Barocas is an accomplished researcher, focusing on quality of life, quality of care, healthcare disparities and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.